Skip to content

Perrigo Company PRGO Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

Kenvue logo
KenvueKVUE
Coty logo
CotyCOTY
CVS Health logo
CVS HealthCVS
Clorox logo
CloroxCLX
Edgewell Personal Care logo
Edgewell Personal CareEPC
Evommune
 logo
Evommune EVMN

Other financials

Income statement

See full
Revenue$969.2M-7.2%
Gross profit$325.5M-17.0%
Operating income-$372.3M-894%
Net income-$398.6M-6,128%
EPS (diluted)-$2.87-5,640%

Balance sheet

See full
Cash & equivalents$357.2M-12.9%
Total debt$3.8B-0.6%
Total equity$2.5B-42.7%
Total assets$8.0B-18.2%

Cash flow

See full
Operating cash flow-$113.6M-76.1%
CapEx$13.8M-45.9%
Free cash flow-$127.4M-41.6%

Valuation

See full
Market cap$1.35B-61.4%
Enterprise value$4.82B-31.9%
P/S0.3×-0.5×

Profitability

See full
Gross margin34.2%-2.2pp
Operating margin-36.9%-41.8pp
Net margin-43.5%-48.6pp
FCF margin4.2%-2.0pp

Returns & leverage

See full
Return on equity-53%-57.7pp
Debt / equity1.5×+0.6×
Current ratio2.7×+0.4×

Where this comes from

Reported directly by Perrigo Company in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: Perrigo Company’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perrigo Company's common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perrigo Company's common stock, shares, outstanding?
Perrigo Company (PRGO) reported common stock, shares, outstanding of $138.1M in Q1 2026.
How has Perrigo Company's common stock, shares, outstanding changed year-over-year?
Perrigo Company's common stock, shares, outstanding increased by 0.7% year-over-year, from $137.2M to $138.1M.
What is the long-term trend for Perrigo Company's common stock, shares, outstanding?
Over 3 years (2022 to 2025), Perrigo Company's common stock, shares, outstanding has grown at a 0.7% compound annual growth rate (CAGR), from $134.7M to $137.6M.